New approach to women’s HIV prevention being studied in U.S. teens

UAB News, June 17, 2015

Researchers at the University of Alabama at Birmingham continue efforts to find safe and effective HIV-prevention methods with a new study in female U.S. teens.

The latest study to be led by UAB, MTN-023/IPM 030, is a Phase IIa study evaluating the safety and acceptability of a vaginal ring containing an antiretroviral (ARV) drug called dapivirine among teenage girls ages 15-17 in the United States.

Read more here